- Wait for vaccine ends: Serum Institute of India, Bharat Biotech get DCGI nod for emergency use The Serum Institute of India (SII) had submitted safety, immunogenicity and efficacy data generated on 23,745 participants aged 18 years or older from overseas clinical studies in which the overall vaccine efficacy was found to be 70.42%……..read more
- How to register for Covid-19 vaccine in India? The vaccination centres will administer the Covid-19 vaccine only to those who have pre-registered in the Co-WIN website or app. Self-registration can be done on the Co-WIN app or website. The prioritisation for the people, who are not healthcare workers, will be based on their age and comorbidities……read more
- India approves vaccines from Bharat Biotech and Oxford/AstraZeneca India has formally approved the emergency use of two coronavirus vaccines as it prepares for one of the world’s biggest inoculation drives…..read more
- SII to sell first 100 million doses of COVID-19 vaccine at ?200 per dose Serum Institute of India will be selling the first 100 million doses of its coronavirus vaccines to the Union government at a “special price” of ?200……read more
- WHO welcomes India’s COVID-19 vaccine approval The World Health Organisation on Sunday welcomed India’s decision giving emergency use authorisation to COVID-19 vaccines, saying it will help “intensify” and “strengthen” its fight against the ongoing pandemic…..read more
- India’s COVID-19 active caseload drops below 2.5 lakh: Health Ministry The COVID-19 active caseload in India has dropped below 2.5 lakh with the recoveries exceeding new cases and low number of fatalities per day ………read more
- India becomes first country to culture U.K. variant strain U.K. variant of the virus, with all signature changes, is now successfully isolated and cultured at the National Institute of Virology (NIV) from the clinical specimens collected from UK-returnees…….read more
- Experts raise questions over ‘hasty’ approval for COVID-19 vaccines Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data……read more